Ryan & Maniskas, LLP Announces Investigation of Anadys Pharmaceuticals Inc.
18 Octobre 2011 - 1:37AM
Business Wire
Ryan & Maniskas, LLP (www.rmclasslaw.com/cases/ands) is
investigating potential claims against the board of directors of
Anadys Pharmaceuticals Inc. ("Anadys" or the "Company") (NASDAQ:
ANDS) concerning possible breaches of fiduciary duty and other
violations of law related to the Company’s efforts to sell Anadys
to Roche Holding AG in a transaction valued at approximately $230
million.
Our investigation concerns possible breaches of fiduciary duty
and other violations of law related to the approval of the
transaction by Company’s board of directors; in particular, whether
the Company undertook a fair process to obtain fair consideration
for all shareholders of Anadys. For more information regarding our
investigation, please contact Ryan & Maniskas, LLP (Richard A.
Maniskas, Esquire) toll-free at (877) 316-3218 or by email at
rmaniskas@rmclasslaw.com or visit:
www.rmclasslaw.com/cases/ands.
Under the terms of the agreement, Anadys shareholders will
receive $3.70 per share of Anadys stock they own.
If you own shares of Anadys and would like to learn more about
these claims or if you wish to discuss these matters and have any
questions concerning this announcement or your rights, contact
Richard A. Maniskas, Esquire toll-free at (877) 316-3218 or to sign
up online, visit: www.rmclasslaw.com/cases/ands. You may also email
Mr. Maniskas at rmaniskas@rmclasslaw.com. For more information
about class action cases in general, please visit our website:
www.rmclasslaw.com.
Ryan & Maniskas, LLP is a national shareholder litigation
firm. Ryan & Maniskas, LLP is devoted to protecting the
interests of individual and institutional investors in shareholder
actions in state and federal courts nationwide.
Anadys (NASDAQ:ANDS)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
Anadys (NASDAQ:ANDS)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024
Real-Time news about Anadys Pharmaceuticals (MM) (NASDAQ): 0 recent articles
Plus d'articles sur Ryan & Maniskas, LLP